Interconnection between Microbiota-Gut-Brain Axis and Autism Spectrum Disorder Comparing Therapeutic Options: A Scoping Review.

autism spectrum disorder diet fecal microbiota transplantation gut health microbiota microbiota transfer therapy microbiota–gut–brain axis nutrition prebiotic probiotic synbiotic

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
01 Jun 2023
Historique:
received: 12 04 2023
revised: 19 05 2023
accepted: 30 05 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Autism spectrum disorder (ASD) is a group of neurodevelopmental illnesses characterized by difficulty in social communication, social interaction, and repetitive behaviors. These clinical diagnostic criteria can be seen in children as early as one year old and are commonly associated with long-term difficulties. ASD is connected with a higher frequency of various medical diseases such as gastrointestinal complaints, seizures, anxiety, interrupted sleep, and immunological dysfunction, in addition to the range of developmental abnormalities listed. From 1 January 2013 to 28 February 2023, we searched PubMed, Scopus and Web of Science for English-language papers that matched our topic. The following Boolean keywords were utilized in the search approach: "autism" AND "microbiota". After deleting duplicates, a total of 2370 publications were found from the databases, yielding 1222 articles. (1148). Nine hundred and eighty-eight items were excluded after their titles and abstracts were scrutinized. The method resulted in the removal of 174 items for being off-topic. The final 18 articles for qualitative analysis are included in the evaluation. The findings of this extensive study revealed that probiotics, prebiotics, their combination as synbiotics, fecal microbiota transplantation, and microbiota transfer therapy may benefit ASD patients suffering from both gastrointestinal and central nervous system symptoms.

Sections du résumé

BACKGROUND BACKGROUND
Autism spectrum disorder (ASD) is a group of neurodevelopmental illnesses characterized by difficulty in social communication, social interaction, and repetitive behaviors. These clinical diagnostic criteria can be seen in children as early as one year old and are commonly associated with long-term difficulties. ASD is connected with a higher frequency of various medical diseases such as gastrointestinal complaints, seizures, anxiety, interrupted sleep, and immunological dysfunction, in addition to the range of developmental abnormalities listed.
METHODS METHODS
From 1 January 2013 to 28 February 2023, we searched PubMed, Scopus and Web of Science for English-language papers that matched our topic. The following Boolean keywords were utilized in the search approach: "autism" AND "microbiota". After deleting duplicates, a total of 2370 publications were found from the databases, yielding 1222 articles. (1148). Nine hundred and eighty-eight items were excluded after their titles and abstracts were scrutinized. The method resulted in the removal of 174 items for being off-topic. The final 18 articles for qualitative analysis are included in the evaluation.
CONCLUSION CONCLUSIONS
The findings of this extensive study revealed that probiotics, prebiotics, their combination as synbiotics, fecal microbiota transplantation, and microbiota transfer therapy may benefit ASD patients suffering from both gastrointestinal and central nervous system symptoms.

Identifiants

pubmed: 37374979
pii: microorganisms11061477
doi: 10.3390/microorganisms11061477
pmc: PMC10303020
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Biomed Res Int. 2018 May 16;2018:4597321
pubmed: 29862271
Transl Psychiatry. 2019 Jan 29;9(1):43
pubmed: 30696816
Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):461-478
pubmed: 31123355
Mol Psychiatry. 2013 Jun;18(6):666-73
pubmed: 22688187
Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):8034-8041
pubmed: 30536353
PLoS One. 2019 Jan 9;14(1):e0210064
pubmed: 30625189
Gut Pathog. 2020 Feb 03;12:6
pubmed: 32025243
PLoS One. 2013 Jun 05;8(6):e65021
pubmed: 23755170
Cell. 2016 Jun 16;165(7):1762-1775
pubmed: 27315483
Materials (Basel). 2022 Jan 31;15(3):
pubmed: 35161065
J Pers Med. 2020 Oct 02;10(4):
pubmed: 33023268
Trends Neurosci. 2013 May;36(5):305-12
pubmed: 23384445
J Biol Regul Homeost Agents. 2018 Sep-Oct;32(5):1329-1334
pubmed: 30334434
J Child Adolesc Psychopharmacol. 2019 Nov;29(9):659-669
pubmed: 31478755
Front Cell Infect Microbiol. 2021 Oct 19;11:759435
pubmed: 34737978
Sci Rep. 2019 Apr 9;9(1):5821
pubmed: 30967657
Children (Basel). 2022 Jul 08;9(7):
pubmed: 35883998
Nutrients. 2022 Aug 26;14(17):
pubmed: 36079777
Cell. 2019 May 30;177(6):1600-1618.e17
pubmed: 31150625
J Clin Med. 2022 Sep 06;11(18):
pubmed: 36142909
J Biol Regul Homeost Agents. 2021 Apr 27;35(2):
pubmed: 33904270
Clin Infect Dis. 2019 Apr 8;68(8):1351-1358
pubmed: 30957161
Microbiome. 2017 Jan 23;5(1):10
pubmed: 28122648
Biomedicines. 2020 May 09;8(5):
pubmed: 32397555
Front Psychol. 2015 Nov 26;6:1805
pubmed: 26635701
Psychiatry Res. 2020 May;287:112922
pubmed: 32203749
mSphere. 2020 Oct 21;5(5):
pubmed: 33087514
BMC Psychiatry. 2022 Aug 8;22(1):536
pubmed: 35941573
FEMS Microbiol Ecol. 2017 Feb;93(2):
pubmed: 27856622
Front Psychiatry. 2017 Aug 23;8:155
pubmed: 28878697
Appl Environ Microbiol. 2011 Sep;77(18):6718-21
pubmed: 21784919
Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8645-8657
pubmed: 31646599
Mol Autism. 2016 Sep 01;7(1):37
pubmed: 27594980
Microbiol Spectr. 2017 Sep;5(5):
pubmed: 28936943
Endocr Metab Immune Disord Drug Targets. 2021;21(7):1356-1365
pubmed: 33167849
J Biol Regul Homeost Agents. 2020 Mar-Apr;34(2):733-737
pubmed: 32492992
Endocr Metab Immune Disord Drug Targets. 2021;21(5):777-784
pubmed: 32727337
Nat Rev Gastroenterol Hepatol. 2020 Nov;17(11):687-701
pubmed: 32826966
Gut. 2016 May;65(5):740-8
pubmed: 26657899
PLoS One. 2014 Jan 22;9(1):e87072
pubmed: 24466331
Int J Mol Sci. 2022 Nov 03;23(21):
pubmed: 36362265
PLoS One. 2012;7(4):e33224
pubmed: 22511918
Clin Ter. 2021 Jan-Feb;171(1):e8-e15
pubmed: 33346320
Nutrients. 2021 May 05;13(5):
pubmed: 34062986
Therap Adv Gastroenterol. 2016 Mar;9(2):229-39
pubmed: 26929784
Physiol Behav. 2015 Jan;138:179-87
pubmed: 25446201
Neuropsychobiology. 2019;78(1):1-6
pubmed: 30947230
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Int J Mol Sci. 2022 Apr 05;23(7):
pubmed: 35409389
J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2 Suppl. 1):295-302
pubmed: 34281326
PLoS One. 2017 Feb 6;12(2):e0171643
pubmed: 28166277
Metab Brain Dis. 2018 Aug;33(4):1155-1164
pubmed: 29582256
Eur Rev Med Pharmacol Sci. 2023 Mar;27(6):2659-2670
pubmed: 37013784
Clin Ter. 2020 May-Jun;171(3):e197-e208
pubmed: 32323706
Endocr Metab Immune Disord Drug Targets. 2019;19(3):373-381
pubmed: 30574857
Physiol Rev. 2019 Oct 1;99(4):1877-2013
pubmed: 31460832
Neuron. 2019 Jan 16;101(2):246-259.e6
pubmed: 30522820
J Affect Disord. 2018 Mar 1;228:13-19
pubmed: 29197739
Autism Res. 2022 Jan;15(1):56-69
pubmed: 34813183
J Biol Regul Homeost Agents. 2019 Apr 30;33(3):977-981
pubmed: 31035741
Biology (Basel). 2020 Oct 01;9(10):
pubmed: 33019595
J Lipid Res. 2013 Sep;54(9):2325-40
pubmed: 23821742
Front Microbiol. 2018 Apr 19;9:757
pubmed: 29725324
J Biol Regul Homeost Agents. 2019 Nov-Dec;33(6):1973-1979
pubmed: 31858774
J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2 Suppl. 1):303-321
pubmed: 34281327
J Biol Regul Homeost Agents. 2018 Sep-Oct;32(5):1323-1328
pubmed: 30334433
Nutrients. 2019 Apr 11;11(4):
pubmed: 30979038
Brain Behav Immun. 2017 Mar;61:36-49
pubmed: 27825953
Mol Autism. 2018 May 30;9:35
pubmed: 29854372
Cell. 2013 Dec 19;155(7):1451-63
pubmed: 24315484
Med Hypotheses. 2015 Apr;84(4):395-401
pubmed: 25670416
Nutrition. 2012 Feb;28(2):124-6
pubmed: 22079796
Microb Ecol Health Dis. 2012 Aug 24;23:
pubmed: 23990817
Pilot Feasibility Stud. 2020 Feb 12;6:20
pubmed: 32082606
Physiol Behav. 2017 Jan 1;168:138-145
pubmed: 27836684
PLoS One. 2022 Feb 24;17(2):e0263109
pubmed: 35202432
BMC Gastroenterol. 2011 Mar 16;11:22
pubmed: 21410934
Microorganisms. 2021 May 14;9(5):
pubmed: 34069179
Front Psychiatry. 2019 Apr 09;10:194
pubmed: 31024357
J Biol Regul Homeost Agents. 2020 Jul-Aug;34(4):1601-1606
pubmed: 32909421
Microbiome. 2018 Aug 2;6(1):133
pubmed: 30071894
Biochem J. 2009 May 13;420(2):211-9
pubmed: 19228118
J Child Neurol. 2000 Jul;15(7):429-35
pubmed: 10921511

Auteurs

Angelo Michele Inchingolo (AM)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Assunta Patano (A)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Fabio Piras (F)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Antonio Mancini (A)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Alessio Danilo Inchingolo (AD)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Gregorio Paduanelli (G)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Francesco Inchingolo (F)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Andrea Palermo (A)

Implant Dentistry College of Medicine and Dentistry Birmingham, University of Birmingham, Birmingham B4 6BN, UK.

Gianna Dipalma (G)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Giuseppina Malcangi (G)

Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Classifications MeSH